Interleukine-6 serum levels correlate with response to antidepressant sleep deprivation and sleep phase advance

F Benedetti, A Lucca, F Brambilla, C Colombo… - Progress in neuro …, 2002 - Elsevier
Unstimulated production of interleukine-6 (IL-6) is known to be enhanced in patients affected
by a major depressive episode. Recent studies supported a role for basal IL-6 levels in …

Chronobiological therapy for mood disorders

S Dallaspezia, M Suzuki, F Benedetti - Current psychiatry reports, 2015 - Springer
Chronobiological therapies for mood disorders include manipulations of the sleep–wake
cycle such as sleep deprivation and sleep phase advance and the controlled exposure to …

Recent progress in pharmacological and non-pharmacological treatment options of major depression

TC Baghai, HJ Moller… - Current pharmaceutical …, 2006 - ingentaconnect.com
In spite of recent progress in the pharmacotherapy of depression major issues are still
unresolved. These include the non-response rate of approximately 30% to conventional …

Sleep and manipulations of the sleep–wake rhythm in depression

M Berger, D Van Calker… - Acta Psychiatrica …, 2003 - Wiley Online Library
Objective: Disturbed sleep is typical for most depressed patients and complaints about
disordered sleep are the hallmarks of the disorder. Polysomnographic sleep research has …

Antidepressant chronotherapeutics for bipolar depression

F Benedetti - Dialogues in clinical neuroscience, 2012 - Taylor & Francis
Chronotherapeutics refers to treatments based on the principles of circadian rhythm
organization and sleep physiology, which control the exposure to environmental stimuli that …

Fluoxetine and sleep EEG: effects of a single dose, subchronic treatment, and discontinuation in healthy subjects

B Feige, U Voderholzer, D Riemann, R Dittmann… - …, 2002 - Elsevier
The goals of the current study were to evaluate whether a single dose of fluoxetine causes
qualitatively different changes in sleep architecture and NREM sleep EEG than subchronic …

OX2R activation induces PKC-mediated ERK and CREB phosphorylation

Y Guo, P Feng - Experimental cell research, 2012 - Elsevier
Deficiencies in brain orexins and components of mitogen activated protein kinase (MAPK)
signaling pathway have been reported in either human depression or animal model of …

Delta sleep ratio as a predictor of sleep deprivation response in major depression

C Nissen, B Feige, A König, U Voderholzer… - Journal of psychiatric …, 2001 - Elsevier
The fast but short-lasting improvement of depressive symptoms by sleep deprivation (SD) in
about 60% of patients with a major depressive disorder is well established, but the …

Augmentation of pharmacotherapy by sleep deprivation with sleep phase advance in treatment-resistant depression

E Kurczewska, E Ferensztajn-Rochowiak… - …, 2019 - thieme-connect.com
Introduction The aim was to assess the efficacy of total sleep deprivation (TSD) with sleep
phase advance (SPA) in treatment-resistant depression (TRD) and associated biochemical …

A multistage chronobiologic intervention for the treatment of depression: a pilot study

L Moscovici, M Kotler - Journal of affective disorders, 2009 - Elsevier
BACKGROUND: Most antidepressant medications in current use have several
disadvantages: a delayed therapeutic effect, side effects, stigmatization and concerns about …